Bridgeport Hospital is now offering Aquablation therapy, a minimally invasive robotic-assisted procedure for men with benign prostatic hyperplasia (BPH), following the program's July 2026 launch.
Aquablation therapy uses advanced imaging, robotics, and a high-velocity, heat-free waterjet to remove excess prostate tissue causing urinary symptoms, designed to provide long-lasting relief while reducing risks associated with traditional surgical approaches.
BPH is one of the most common health conditions affecting aging men, with approximately half of men experiencing it by their early 60s, rising to roughly 70% between ages 60 and 69 and around 80% over 70. More than 7.3 million people in the U.S. had a BPH diagnosis in 2025, with cases nationally projected to rise from 14 million in 2020 to over 18 million by 2030. Common symptoms include frequent urination, difficulty starting urination, a weak urinary stream, and interrupted sleep due to nighttime bathroom visits.
Steven Kardos, MD, chief of Urology at Bridgeport Hospital, said, "For many men, symptoms of an enlarged prostate gradually become something they simply learn to live with, affecting everything from sleep to travel to daily activities. Aquablation gives us an important new option to help patients find lasting relief while preserving quality of life. It's changing the conversation around treatment because men no longer have to choose between living with bothersome symptoms and concerns about the side effects of surgery."
Aquablation therapy expands the range of advanced urologic treatments available at Bridgeport Hospital, reflecting the hospital's commitment to patient-centered care through proven medical innovations.
"At Bridgeport Hospital, we are continually evaluating new technologies and treatments that have the potential to improve our patients' lives," said Anne Diamond, DBA, JD, president of Bridgeport Hospital. "By offering Aquablation therapy, we're expanding access to an innovative procedure that can make a meaningful difference for men experiencing the challenges of an enlarged prostate. It's another example of our commitment to providing advanced care close to home."
